Assignee
NALPROPION PHARMACEUTICALS LLC
US7 patents
Top patents by PatentIndex Score
US11998542B2Jun 4, 2024
Compositions and methods for reducing major adverse cardiovascular events
NALPROPION PHARMACEUTICALS LLC3 citations84
US10835527B2Nov 17, 2020
Compositions and methods for reducing major adverse cardiovascular events
NALPROPION PHARMACEUTICALS LLC6 citations83
US10828294B2Nov 10, 2020
Compositions and methods for weight loss in at risk patient populations
NALPROPION PHARMACEUTICALS LLC6 citations83
US11278544B2Mar 22, 2022
Compositions for affecting weight loss
NALPROPION PHARMACEUTICALS LLC4 citations82
US12048769B2Jul 30, 2024
Methods for administering weight loss medications
NALPROPION PHARMACEUTICALS LLC3 citations73
US11139056B2Oct 5, 2021
Methods of treating overweight and obesity
NALPROPION PHARMACEUTICALS LLC4 citations72
US11033543B2Jun 15, 2021
Methods of providing weight loss therapy in patients with major depression
NALPROPION PHARMACEUTICALS LLC3 citations71